Phage Based Diagnostics

01359 231856

funding

Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022

Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic with potential to revolutionise management of TB.

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022

Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic...

developers of phage-based diagnostics

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

design: out of house

PBD Biotech

Actiphage only test for subclinical tuberculosis that detects mycobacteria in blood @TAGTeam_Tweets Pipeline Report 2022 reveals of the 10.6m people who developed active TB last year, only 6.4m were diagnosed. A vast unmet need #endTB

PBD Biotech

New Pipeline report @TAGTeam_Tweets says investment in R&D for TB diagnostics R&D reached an all time high in 2020. Interesting description of 'acoustic epidemiology' AI-based tools that detect and monitor cough & lung sounds as biomarker for TB #EndTB

PBD Biotech

Very useful explanation of latent TB infection from @CDC_TB and importance of preventative treatment. #EndTB